Journal
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 133, Issue 3, Pages 654-661Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2014.01.012
Keywords
Airway remodeling; asthma; asthma control; asthma exacerbations; early intervention in asthma; biomarkers; environment; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting beta-adrenergic agonists; personalized medicine; severe asthma; therapeutics
Categories
Funding
- Public Health Services Research Grants [AI-90052, ES-18181, HL-98075]
- Denver Post Charities, a McCormick Foundation
- Colorado Cancer, Cardiovascular and Pulmonary Disease Program
- National Center for Research Resources/National Institutes of Health (NIH) [UL1 RR025780]
- NIH/National Center for Advancing Translational Sciences [UL1 TR000154]
Ask authors/readers for more resources
Last year's Advances in pediatric asthma: moving toward asthma prevention concluded that We are well on our way to creating a pathway around wellness in asthma care and also to utilize new tools to predict the risk for asthma and take steps to not only prevent asthma exacerbations but also to prevent the early manifestations of the disease and thus prevent its evolution to severe asthma. This year's summary will focus on recent advances in pediatric asthma on prenatal and postnatal factors altering the natural history of asthma, assessment of asthma control, and new insights regarding potential therapeutic targets for altering the course of asthma in children, as indicated in Journal of Allergy and Clinical Immunology publications in 2013 and early 2014. Recent reports continue to shed light on methods to understand factors that influence the course of asthma, methods to assess and communicate levels of control, and new targets for intervention, as well as new immunomodulators. It will now be important to carefully assess risk factors for the development of asthma, as well as the risk for asthma exacerbations, and to improve the way we communicate this information in the health care system. This will allow parents, primary care physicians, specialists, and provider systems to more effectively intervene in altering the course of asthma and to further reduce asthma morbidity and mortality.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available